Science Explorer Interactive view Map
Hospital / health system · Denver · United States

Rocky Mountain Cancer Centers

In research, Rocky Mountain Cancer Centers stands highest in Medicine (#12,905 of 17,978 worldwide) and Health Sciences (#15,978 of 20,462 worldwide), over all time. Relative to its size it is most specialised in Medicine — Medicine is 4.2× its share of world research.

rockymountaincancercenters.comROR OpenAlex
World rank, all time
#30,585
of 42,892
Rank in United States
#6,546
of 8,685
Research works
208
▲ 37% vs 2013–17
Citations
4.6k
22.0 per fractional work
Top-10% rate
10.5%
record average 16.5%
Open access
29%
world 28%

What is Rocky Mountain Cancer Centers known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
MedicineField #12,905 of 17,978 14.5%159
Health SciencesDomain #15,978 of 20,462 14.6%162

Each strip is that field’s whole ranked pool, with the notch where Rocky Mountain Cancer Centers sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

What does Rocky Mountain Cancer Centers specialise in?

Where its research is concentrated relative to its size: Medicine takes 4.2× the share of its output that it takes of world research.

  1. MedicineField · 41.0 works4.2×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 1.71× its world share, 5 worksBiochemistry, Geneti…Immunology and Microbiology: 2.64× its world share, 1 worksImmunology and Micro…Neuroscience: 0.08× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 1.00× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.52× its world share, 0 worksChemistryEnvironmental Science: 0.03× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.02× its world share, 0 worksMaterials ScienceMathematics: 0.14× its world share, 0 worksMathematicsPhysics and Astronomy: 0.18× its world share, 0 worksPhysics and AstronomyHealth Professions: 0.39× its world share, 0 worksHealth ProfessionsMedicine: 4.17× its world share, 41 worksMedicineNursing: 0.66× its world share, 0 worksNursingEconomics, Econometrics and Finance: 1.94× its world share, 2 worksEconomics, Econometr…Psychology: 0.07× its world share, 0 worksPsychologySocial Sciences: 0.02× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.2×. Every wedge is a field page.

Who are the top researchers at Rocky Mountain Cancer Centers?

Ranked on the composite score, John M. Burke, Robert M. Rifkin and Robert M. Jotte lead among researchers whose main affiliation is Rocky Mountain Cancer Centers.

  1. 1 John M. Burke United States · #167,187 worldwide 167 citations · 36 works
  2. 2 Robert M. Rifkin United States · #411,738 worldwide 68 citations · 33 works
  3. 3 Robert M. Jotte United States · #432,985 worldwide 84 citations · 26 works
  4. 4 Allen Lee Cohn United States · #926,068 worldwide 20 citations · 32 works
  5. 5 David Andorsky United States · #1,096,454 worldwide 22 citations · 16 works
  6. 6 Sami Diab United States · #1,219,327 worldwide 20 citations · 16 works
All ranked researchers at Rocky Mountain Cancer Centers

Which keywords describe research at Rocky Mountain Cancer Centers?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Rituximab, Lymphoma, Prognostic Factors, PET Imaging, Gene Expression Profiling, Molecular Profiling, Classification and Genetic Pathogenesis.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Rituximab12▲ 151×2 topics
  2. Lymphoma9▲ 113×3 topics
  3. Prognostic Factors9▲ 40×10 topics
  4. PET Imaging7▲ 79×4 topics
  5. Gene Expression Profiling6▲ 148×2 topics
  6. Molecular Profiling6▲ 122×2 topics
  7. Classification6▲ 26×2 topics
  8. Genetic Pathogenesis6▲ 218×1 topic
  9. Hodgkin's Lymphoma6▲ 218×1 topic
  10. Immunotherapy6▲ 16×11 topics
  11. Chronic Lymphocytic Leukemia6▲ 242×1 topic
  12. Genomic Aberrations6▲ 242×1 topic
  13. Therapeutic Targets6▲ 72×2 topics
  14. Chemotherapy5▲ 13×15 topics
  15. Targeted Therapy4▲ 34×4 topics
  16. Cancer Immunotherapy4▲ 47×3 topics
  17. Clinical Trials3▲ 9.8×8 topics
  18. Tumor Regression3▲ 60×2 topics
  19. CAR T Cells3▲ 87×1 topic
  20. Chimeric Antigen Receptor3▲ 87×1 topic
  21. Leukemia3▲ 77×2 topics
  22. Breast Cancer3▲ 26×4 topics
  23. Minimal Residual Disease3▲ 73×2 topics
  24. Genomic Profiling2▲ 43×2 topics
  25. Tumor Microenvironment2▲ 9.7×7 topics
  26. ALK Inhibitors2▲ 65×1 topic
  27. BCR-ABL2▲ 152×1 topic
  28. EGFR Mutations2▲ 65×1 topic
  29. Imatinib2▲ 152×1 topic
  30. Treatment Guidelines2▲ 19×2 topics
  31. Precision Medicine2▲ 8.1×3 topics
  32. Metastasis2▲ 10×7 topics
  33. Monoclonal Antibodies2▲ 37×2 topics
  34. Metastatic Breast Cancer2▲ 57×2 topics
  35. Staging System2▲ 53×2 topics
  36. Neoadjuvant Therapy2▲ 13×4 topics
  37. Diagnosis Criteria1▲ 78×1 topic
  38. Immune Checkpoint Blockade1▲ 26×1 topic
  39. PD-1 and PD-L11▲ 26×1 topic
  40. Proteasome Inhibitors1▲ 40×2 topics

Which research topics does Rocky Mountain Cancer Centers publish most on?

By volume in 2022–2025: Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, CAR-T cell therapy research and Chronic Myeloid Leukemia Treatments.

Lymphoma Diagnosis and T…6Lymphoma Diagnosis and Treatment: 6 fractional worksChronic Lymphocytic Leuk…6Chronic Lymphocytic Leukemia Research: 6 fractional worksCAR-T cell therapy research: 3 fractional worksChronic Myeloid Leukemia…2Chronic Myeloid Leukemia Treatments: 2 fractional worksLung Cancer Treatments a…2Lung Cancer Treatments and Mutations: 2 fractional worksCancer Immunotherapy and…1Cancer Immunotherapy and Biomarkers: 1 fractional worksMultiple Myeloma Research and Treatments: 1 fractional worksBRCA gene mutations in cancer: 1 fractional worksEconomic and Financial Impacts of Cancer: 1 fractional worksAcute Lymphoblastic Leukemia research: 1 fractional works
Pathology and Forensic MedicineGeneticsOncologyHematology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 6 works
  2. 2 Chronic Lymphocytic Leukemia Research Genetics 6 works
  3. 3 CAR-T cell therapy research Oncology 3 works
  4. 4 Chronic Myeloid Leukemia Treatments Hematology 2 works
  5. 5 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 2 works
  6. 6 Cancer Immunotherapy and Biomarkers Oncology 1 works
  7. 7 Multiple Myeloma Research and Treatments Hematology 1 works
  8. 8 BRCA gene mutations in cancer Genetics 1 works
  9. 9 Economic and Financial Impacts of Cancer Economics and Econometrics 1 works
  10. 10 Acute Lymphoblastic Leukemia research Public Health, Environmental and Occupational Health 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available29.0%not open71.0%

World: 28% of research is openly available.

with international co-authors25.6%domestic only74.4%

World: 19% is written across borders.

How has Rocky Mountain Cancer Centers's research output changed?

Output in 2018–2022 was 37% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Denver

All research institutions in Denver

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.